{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:54:51Z","timestamp":1773924891509,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010814","name":"Anhui Province Department of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cellsig.2025.112314","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T02:31:33Z","timestamp":1765593093000},"page":"112314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["USP9X promotes acute myeloid leukemia progression and adriamycin resistance by regulating METTL7A deubiquitination"],"prefix":"10.1016","volume":"139","author":[{"given":"Zhou","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Siyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Siyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan","family":"YuanYuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiajia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2025.112314_bb0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2025.112314_bb0010","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1073\/pnas.1902375116","article-title":"Heterogeneity in refractory acute myeloid leukemia","volume":"116","author":"Horibata","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2025.112314_bb0015","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2025.112314_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/blood-2015-07-604546","article-title":"Hematopoietic stem cell transplantation for patients with AML in first complete remission","volume":"127","author":"Cornelissen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2025.112314_bb0025","first-page":"530","article-title":"Hematopoietic cell transplantation in the treatment of pediatric acute myelogenous leukemia and myelodysplastic syndromes: guidelines from the American Society of Transplantation and cellular therapy","volume":"28","author":"Tarlock","year":"2022","journal-title":"Transpl. Cell. Ther."},{"key":"10.1016\/j.cellsig.2025.112314_bb0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","article-title":"AML treatment: conventional chemotherapy and emerging novel agents","volume":"45","author":"Forsberg","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cellsig.2025.112314_bb0035","first-page":"736","article-title":"Mechanism of apoptosis for resveratrol-mediated reversing the drug-resistance of AML HL-60\/ADR cells","volume":"25","author":"Guo","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.cellsig.2025.112314_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-021-00320-w","article-title":"Deubiquitinases in hematological malignancies","volume":"9","author":"Lei","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cellsig.2025.112314_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02705243","article-title":"The ubiquitin-proteasome system","volume":"31","author":"Nandi","year":"2006","journal-title":"J. Biosci."},{"key":"10.1016\/j.cellsig.2025.112314_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamcr.2013.09.009","article-title":"The ubiquitin-proteasome-system","volume":"1843","author":"Sommer","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2025.112314_bb0055","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1172\/JCI126414","article-title":"USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells","volume":"129","author":"Chen","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2025.112314_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05527-9","article-title":"USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells","volume":"14","author":"Zhao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.112314_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-024-03321-9","article-title":"USP9X regulates the proliferation, survival, migration and invasion of gastric cancer cells by stabilizing MTH1","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.cellsig.2025.112314_bb0070","article-title":"Usp9x increased tumor angiogenesis in mantle cell lymphoma by upregulation of Ccnd1- mediated Sox11","volume":"14","author":"Huang","year":"2022","journal-title":"Mediterranean J. Hematol. Infect. Dis."},{"key":"10.1016\/j.cellsig.2025.112314_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1746-1596-8-177","article-title":"USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma","volume":"8","author":"Peng","year":"2013","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.cellsig.2025.112314_bb0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neo.2017.11.007","article-title":"Usp9x promotes survival in human pancreatic Cancer and its inhibition suppresses pancreatic ductal adenocarcinoma in vivo tumor growth","volume":"20","author":"Pal","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.cellsig.2025.112314_bb0085","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1002\/cam4.2528","article-title":"USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells","volume":"8","author":"Lu","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.cellsig.2025.112314_bb0090","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4149\/neo_2021_201227N1410","article-title":"Knockdown of USP9X reverses cisplatin resistance by decreasing \u03b2-catenin expression in nasopharyngeal carcinoma cells","volume":"68","author":"Lu","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.cellsig.2025.112314_bb0095","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/s41418-021-00740-z","article-title":"USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-\u03b22 transcription","volume":"28","author":"Jie","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2025.112314_bb0100","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.7150\/thno.22901","article-title":"A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer","volume":"8","author":"Chen","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2025.112314_bb0105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.15252\/emmm.201506047","article-title":"USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma","volume":"8","author":"Engel","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cellsig.2025.112314_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105055","article-title":"Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival","volume":"299","author":"Wang","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.112314_bb0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2019.03.046","article-title":"Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress","volume":"453","author":"Akiyama","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2025.112314_bb0120","article-title":"Transcriptomic characterization revealed that METTL7A inhibits melanoma progression via the p53 signaling pathway and immunomodulatory pathway","volume":"11","author":"Zhang","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.cellsig.2025.112314_bb0125","article-title":"Pan-cancer analysis reveals potential immunological and prognostic roles of METTL7A in human cancers","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2025.112314_bb0130","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.14283\/jpad.2024.119","article-title":"Leveraging diverse regulated cell death patterns to identify diagnosis biomarkers for Alzheimer\u2019s disease","volume":"11","author":"Ren","year":"2024","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.cellsig.2025.112314_bb0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbrc.2015.02.115","article-title":"Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance","volume":"459","author":"Zhou","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2025.112314_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1158\/1535-7163.MCT-23-0144","article-title":"The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors","volume":"23","author":"Robey","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2025.112314_bb0145","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/nar\/gkx1226","article-title":"USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2025.112314_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-021-01416-w","article-title":"Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia","volume":"36","author":"de Beauchamp","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2025.112314_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094955","article-title":"Inhibitors of Chemoresistance pathways in combination with Ara-C to overcome multidrug resistance in AML. A mini review","volume":"22","author":"Fajardo-Ordu\u00f1a","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.112314_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","article-title":"Deubiquitinase inhibition as a cancer therapeutic strategy","volume":"147","author":"D\u2019Arcy","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cellsig.2025.112314_bb0165","first-page":"2019","article-title":"Functional analysis of deubiquitylating enzymes in tumorigenesis and development","volume":"188312","author":"Cheng","year":"1872","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.112314_bb0170","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1074\/jbc.RA118.006057","article-title":"Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.112314_bb0175","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41388-018-0134-2","article-title":"The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2025.112314_bb0180","doi-asserted-by":"crossref","first-page":"49033","DOI":"10.18632\/oncotarget.16931","article-title":"WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2025.112314_bb0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.112314_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110989","article-title":"The thiol methyltransferase activity of TMT1A (METTL7A) is conserved across species","volume":"394","author":"Gonz\u00e1lez Dalmasy","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cellsig.2025.112314_bb0195","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/dmd.123.001268","article-title":"METTL7A (TMT1A) and METTL7B (TMT1B) are responsible for AlkylS-thiol methyl transferase activity in liver","volume":"51","author":"Russell","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cellsig.2025.112314_bb0200","article-title":"Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer","author":"Starble","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.cellsig.2025.112314_bb0205","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02209-w","article-title":"Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112314_bb0210","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1111\/jcmm.16706","article-title":"PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cellsig.2025.112314_bb0215","article-title":"TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKK\u03b2\/AMPK\u03b1\/mTOR pathway","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2025.112314_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.763500","article-title":"Ad-Apoptin-hTERTp-E1a regulates autophagy through the AMPK-mTOR-eIF4F signaling Axis to reduce drug resistance of MCF-7\/ADR cells","volume":"8","author":"Li","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cellsig.2025.112314_bb0225","first-page":"491","article-title":"GL-V9 reverses adriamycin resistance in hepatocellular carcinoma cells by affecting JNK2-related autophagy","volume":"18","author":"Yang","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.cellsig.2025.112314_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10142-024-01304-3","article-title":"MHY1485 promotes adriamycin sensitivity in HepG2 cells by inhibiting autophagy","volume":"24","author":"Guo","year":"2024","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.cellsig.2025.112314_bb0235","article-title":"S100A8 contributes to drug resistance by promoting autophagy in leukemia cells","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2025.112314_bb0240","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41419-021-04336-w","article-title":"TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT\/mTOR signaling","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.112314_bb0245","first-page":"1665","article-title":"hnRNP K contributes to Adriamycin resistance in acute myeloid leukemia through regulating autophagy","volume":"24","author":"Zhang","year":"2016","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.cellsig.2025.112314_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-022-00342-8","article-title":"METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner","volume":"27","author":"Dai","year":"2022","journal-title":"Cell. Mol. Biol. Lett."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:07:02Z","timestamp":1773911222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825007296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"alternative-id":["S0898656825007296"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112314","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP9X promotes acute myeloid leukemia progression and adriamycin resistance by regulating METTL7A deubiquitination","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112314"}}